Merck Seeks To Quash Ranbaxy's Subpoenas
Merck & Co. Inc. has taken its frustrations over multiple subpoenas from generic-drug maker Ranbaxy Pharmaceuticals Inc. to a judge, claiming that the requests for information on Merck's blood pressure drug...To view the full article, register now.
Already a subscriber? Click here to view full article